Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Isentress + Truvada for HIV Post-Exposure Prophylaxis
NCT01114425Phase 3Completed
- Sponsor
- GERES
- Start
- Nov 2010
- Primary completion
- Aug 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of raltegravir in human immunodeficiency virus infection (HIV), sponsored by GERES. Started Nov 2010; status: completed.
02
Drugs
raltegravir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT01114425.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01114425.